Objective: To determine the incidence of ventilator associated pneumonia (VAP) in the intensive care unit, and to characterize most common causative pathogens and resistance pattern. To evaluate compliance to VAP prevention strategies and their documentation in order to identify areas for quality improvement. 
Introduction
Ventilator associated pneumonia (VAP) continues to be an important cause of morbidity and mortality, especially at the setting of Intensive Care Unit (ICU). It is the leading cause of death among nosocomial infections, (1,2) accounting for a hospital mortality ratio of 46%. (1) It has been estimated that VAP prolongs time patients remains on the ventilator and total length of hospital stay. ( 3) The economical impact has been tremendous, exceeding $40,000 for every patient.
VAP is defi ned as a pulmonary infection that develops in patients on mechanical ventilation after 48 hours of intubation. (5) A combination of clinical, radiographic and laboratory data should be considered for patients with suspected VAP. (6,7) If a ventilated patient develops a new or progressive infi ltrate, with fever, leukocytosis, purulent sputum and hypoxemia, the diagnosis of VAP should be considered.
Important sources of infection include healthcare devices, general ICU environment and the transfer between patients-staff and then to other patients. (7, 8, 9) Pathogenesis has been mainly related to the access of nosocomial pathogens into the lower respiratory tract by aspiration of oropharyngeal pathogens or leakage around the endotracheal tube cuff. (7) For these reasons, all healthcare professionals should make efforts to practice effective preventive strategies to prevent this mortal complication.
The purpose of our study was to determine the incidence of VAP in the ICU, and to characterize the most common causative pathogens and resistance pattern. Since our institution has an Internal Medicine Residency and a recently developed Pulmonary fellowship, we also intended to evaluate compliance to VAP prevention strategies and their documentation in order to identify areas for quality improvement and consequently have a positive impact to decrease the rate of this complication.
Methods
Our study was approved by our Institutional Review Board. A retrospective single center study was performed at the ICU at a metropolitan municipal hospital in Puerto Rico. This is a multidisciplinary unit that combines medical, surgical, cardiac, gynecological and obstetrics patients, with a total of 8 beds. Medical records were reviewed for all patients on mechanical ventilator admitted to ICU from January to December 2007. Patients were excluded if they were intubated for less than 48 hours, or if the reason for intubation was suspected to be a hospital acquired pneumonia. The Clinical Pulmonary Infection Score (CPIS) as well as problem list documented by physicians were used to identify VAP cases. Data of microbial isolates and antimicrobial resistance were collected as well as documentation of measures to prevent VAP. Only medical patients were included in the study.
Results
Within the study period, a total of 60 patients at the ICU required mechanical ventilation for more than 48 hours. Of the above number of patients, 25 of them were diagnosed with VAP according to a CPIS greater than six, medical record problem list and clinical, laboratory, and radiographical criteria. The overall estimated VAP rate was 37.15. The most common reasons for intubation and mechanical ventilation were cerebrovascular accidents, community acquired pneumonia and cardiac complications ( Table 1) .
VAP cases were classifi ed as early and late onset. The characteristics as well as compliance to VAP preventive measures are described for each group on Tables 2 and 3, respectively. An extremely low compliance to head of bed elevation, daily sedation interruption and oral care were identifi ed. Among the 25 microbial isolates, the most common pathogens identifi ed in both groups were Klebsiella species, Acinetobacter baumanii, and Pseudomonas aeruginosa ( Table 4 ,5). All of these were identifi ed as multidrug resistant pathogens.
Discussion
In this single center observational study more than one third of patients receiving mechanical ventilation developed ventilator-associated pneumonia (41%), which is higher than the expected 10 to 25% incidence for VAP. (2) These fi ndings may refl ect the lack of compliance to VAP preventive measures as part of the routine management of patients in mechanical ventilation at this teaching institution. Most common pathogens found on sputum culture include Pseudomonas, Klebsiella, Acinetobacter, Enterobacter, Serratia and E. coli, which are expected for hospital acquired pneumonia microorganisms. (7) However, pathogen results differ from what is expected for early onset VAP. It has been established that early onset pneumonia is caused by pathogens such as Pneumococci, Staphylococci, Enterobacteriacea, and Haemophilus species (10) that may gain access to the lower respiratory tract during the process of intubation. Our early onset patients were infected with pathogens common to late onset VAP as Pseudomonas, Acinetobacter, Staphylococcus, and Klebsiella. This may respond to the fact that some of these patients received previous treatment with antibiotics due to another infectious process prior to the development of VAP. The risk for colonization and contamination with multidrug resistant pathogens is higher in this situation, for which their fl ora is similar to late onset VAP patients. These situations may also refl ect the possibility that these patients had a hospital acquired pneumonia that was not identifi ed at the time of intubation and was then diagnosed as a VAP.
The most common microbial isolates among early and late onset VAP cases were multidrug resistant pathogens. Although data about antimicrobial agents used are not shown, most of the patients were treated with three or more antibiotics. This fi nding may be in part the result of multiple medical staff interventions in a teaching hospital, as well as the delay in the timely availability of microbial isolates results. The use of multiple antimicrobial agents may be the contributing factor to multidrug resistance in this institution that lacks an antibiotic rotation program.
This study provided extremely valuable information regarding medical practice in our ICU. As part of a new Pulmonary Fellowship program, quality improvement strategies are being developed and continuously evaluated. Our team pursues better documentation of preventive strategies among all healthcare professionals that have direct contact with patients, including nurses, respiratory therapists, residents, fellows and attending physicians. Endotracheal tube cuff pressure measure is being documented as well as head of bed elevation, by respiratory therapists twice per shift. Intensive care unit and ventilator order sets are also being created to ensure that every measure is being taken to prevent this dreadful complication. These orders include head of bed elevation, stress ulcer and thromboembolism prophylaxis and daily interruption of sedative medications.
Limitations of this study include a single center scenario as well as the retrospective assessment of VAP cases. Although data used to evaluate and identify every case involved clinical, laboratory, and radiography criteria, as well as the CPIS, these do not guarantee the real facts as when data is being collected in a prospective study. Thus, we intend to repeat this study after all quality improvement strategies are established and with a prospective evaluation. We will compare results from both studies to determine the impact of these in the VAP rate of our institution. 
